GMJ Technologies LLC (AKA: GMJ) Profile last edited on: 1/27/2021
CAGE: 83DC1
UEI: JUAVBGF9MAK9
Business Identifier: NO Business Identifier is currently available for this company. 
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
Location Information
Location: Single
Congr. District: 07
County: Snohomish
Congr. District: 07
County: Snohomish
Public Profile
GMJ Technologies LLC, spun out of the University of Washington, develops micro-scale analytical technologies for protein characterization. The company uses robust fluidic and detection mechanisms to develop novel capillary electrophoresis (CE) systems for efficient characterizations of biomolecules. The technologies utilize next generation capillary electrophoresis with UV detection, Laser-Induced Fluorescence (LIF) detection, and/or mass spectrometry (MS) to enable powerful applications in biopharmaceutical and biomedical protein characterization. The company's products include next generation capillary electrophoresis with mass spectrometry (CE-ESI-MS) instrument and aftermarket products (accessories, consumables, reagents, and applications) and services for life science applications.
Extent of SBIR involvement
Synopsis: Awardee Business Condition
Employee Range
1-4Revenue Range
0VC funded?
NoPublic/Private
Privately HeldStock Info
----IP Holdings
5-9Awards Distribution by Agency
Most Recent SBIR Projects
| Year | Phase | Agency | Total Amount | |
|---|---|---|---|---|
| 1742209554 | 2 | NIH | $350,001 | |
| Project Title: High-Resolution Native Capillary Zone Electrophoresis with Inline UV and Native Mass Spectrometry for Characterizing Charge Variants in Biologics | ||||
| 2023 | 1 | NIH | $358,862 | |
| Project Title: Sodium Dodecyl Sulfate Removal Interface to Enable Characterization of Fragment Impurities in Monoclonal Antibodies by Capillary Electrophoresis Sodium Dodecyl Sulfate Coupled to Mass Spectrometry | ||||
| 2021 | 2 | NSF | $1,420,701 | |
| Project Title: Next-Generation Capillary Electrophoresis with Mass Spectrometry for Biopharmaceutical and Biomedical Applications | ||||
Key People / Management
Tosin (Oluwatosin) Dada -- Principal/CEO
David Latta -- Advisor, Business Development
David Latta -- Advisor, Business Development
Company News
There are no news available.
